CAS 149-64-4
:Buscopan
- (1S,2R,4S,5S)-9-butyl-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide
- (1S,2R,4S,5S)-9-butyl-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9-methyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane bromide
- 1α<span class="text-smallcaps">H</smallcap>,5α<smallcap>H</span>-Tropanium, 8-butyl-6β,7β-epoxy-3α-hydroxy-, bromide, (-)-tropate
- 3-Oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane, 9-butyl-7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9-methyl-, bromide, [7(S)-(1α,2β,4β,5α,7β)]-
- 3-Oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane, 9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide (1:1), (1α,2β,4β,5α,7β)-
- 3-Oxa-9-azoniatricyclo[3.3.1.0<sup>2,4</sup>]nonane, 9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide, (1α,2β,4β,5α,7β)-
- Amisepan
- Buscapine
- Buscol
- Buscolamin
- Buscolysin
- Buscolysine
- Buscopan
- Butylmin
- Butylscopolamine bromide
- Butylscopolammonium bromide
- Donopon
- Hyoscine Butylobromide
- Hyoscine butobromide
- Hyoscine butyl bromide
- Hyoscine butylbromide
- Hyoscine-N-Butyl Bromide
- Hyoscinen butylbromide
- Joscine
- Monospan
- N-Butylhyoscine bromide
- N-Butylscopolamine bromide
- N-Butylscopolaminium bromide
- N-Butylscopolammonium bromide
- N-butylhyoscinium bromide
- Scobro
- Scobron
- Scobutil
- Scobutyl
- Scopolamine Butylbromide
- Scopolamine bromobutylate
- Scopolamine butobromide
- Scopolamine butyl bromide
- Scopolan
- Sparicon
- Sporamin
- Sporamin (pharmaceutical)
- Stibron
- Tirantil
- Tropic acid, (-)-, ester with 8-butyl-6β,7β-epoxy-3α-hydroxy-1α<span class="text-smallcaps">H</smallcap>,5α<smallcap>H</span>-tropanium bromide
- 1αH,5αH-Tropanium, 8-butyl-6β,7β-epoxy-3α-hydroxy-, bromide, (-)-tropate
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide (1:1), (1α,2β,4β,5α,7β)-
- 3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 9-butyl-7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9-methyl-, bromide, (1α,2β,4β,5α,7β)-
- Ver mais sinónimos
Buscopan
CAS:Fórmula:C21H30BrNO4Pureza:>98.0%(T)(HPLC)Cor e Forma:White to Light yellow powder to crystalPeso molecular:440.38HYOSCINE BUTYLBROMIDE CRS
CAS:HYOSCINE BUTYLBROMIDE CRSFórmula:C21H30BrNO4Cor e Forma:Crystalline Powder. White. Powder.Peso molecular:440.3712HYOSCINE BUTYLBROMIDE FOR SYSTEM SUITABILITY CRS
CAS:HYOSCINE BUTYLBROMIDE FOR SYSTEM SUITABILITY CRSHyoscine butylbromide
CAS:Hyoscine butylbromideFórmula:C21H30BrNO4Pureza:99.7%Cor e Forma:WhitePeso molecular:439.13582Scopolamine butylbromide, EP grade
CAS:Fórmula:C21H30BrNO4Pureza:≤ 0.10% (HPLC)Cor e Forma:White or almost white crystalline powderPeso molecular:440.37Hyoscine Butylbromide (N-Butyl Scopolamine Bromide, N-Butyl Hyoscine Bromide)
CAS:Fórmula:C21H30NO4·BrCor e Forma:White To Off-White SolidPeso molecular:360.47 79.90Scopolamine butylbromide
CAS:Fórmula:C21H30BrNO4Pureza:(Titration) 98.0 - 102.0 % (dried basis)Cor e Forma:White or almost white crystalline powderPeso molecular:440.37Hyoscine Butylbromide-d9 (N-Butyl Scopolamine Bromide-d9, N-Butyl Hyoscine Bromide-d9)
CAS:Fórmula:C21H21D9NO4·BrCor e Forma:White To Off-White SolidPeso molecular:369.53 79.90Scopolamine butylbromide
CAS:Scopolamine butylbromide ((-)-Scopolamine butylbromide) is a competitive antagonist of mAChR (IC50: 55.3 ± 4.3 nM).Fórmula:C21H30NO4·BrPureza:99.02% - 99.95%Cor e Forma:White PowderPeso molecular:440.37N-Butylscopolammonium Bromide-d9
CAS:Produto ControladoStability Hygroscopic
Applications N-Butylscopolammonium Bromide (B693752) acts as an anticholinergic and antispasmodic. This is the labeled analog.
References Lee, J.R., et al.: Clin. Radiol., 33, 273 (1982), Bauer, et al.: Arzneim.-Forsch., 18, 1132 (1986), Steger, A.C., et al.: Am. J. Gastroenterol., 81, 615 (1986),Fórmula:C21H21D9NO4•BrCor e Forma:Off-WhitePeso molecular:369.52799(-)-Scopolamine N-butyl bromide
CAS:(-)-Scopolamine N-butyl bromide is an anti-cholinergic drug that is used for the diagnosis and treatment of bowel diseases. It has been shown to be effective in two different animal models of bowel disease, one of which was induced by dextran sulfate sodium. (-)-Scopolamine N-butyl bromide has been shown to decrease motility and increase tone in the colon, as well as reduce the severity of diarrhea in animals with experimental colitis. It also has a sedative effect on the gastrointestinal tract that may be due to its ability to bind to acetylcholine receptors.
Fórmula:C21H30NO4BrPureza:Min. 98 Area-%Cor e Forma:White PowderPeso molecular:440.37 g/molRef: 3D-FS10191
Produto descontinuado













